News
0
A number of new COVID-19 developments have emerged in April already: AstraZeneca has halted the trial of its COVID-19 vaccine on children amid blood-...
0
Exscientia and Evotec have announced that they are entering an AI-designed immuno-oncology drug into Phase I trials for the first time ever.
0
Moderna have published antibody persistence data out to six months following the second dose of its COVID-19 vaccine (mRNA-1273) in The New England...
0
Results from Eli Lily and Incyte’s Phase III study, COV-BARRIER, evaluating baricitinib in the treatment of hospitalised COVID-19 patients did not...
Features
As NICE approves the most expensive drug ever for use by the NHS, Jack Goddard takes a look at drug pricing in the UK, how it...
Featured Appointment
Intravac have announced the appointment of Nathalie Laarakker as its new CFO and member of the company’s executive management team.
...
Service Company News
Featured Event
11/01/2021 - 15/01/2021 -
Virtual Event,
@Pharmafocus
